International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2025   Volume 15   Issue 5

Responsible AI for Phytopharmaceutical Innovation: Scientific Validity, Ethical Sourcing, Explainability, Reproducibility, and Clinical Trust
Download PDF


, ,
  1. Department of AI for Tropical Plant Metabolomics, Faculty of Pharmacy, University of Malaya, Kuala Lumpur, Malaysia.
  2. Department of Computational Pharmacology for Anti-Diabetic Compounds, Faculty of Pharmacy, Universiti Sains Malaysia, Penang, Malaysia.
Citation
Vancouver
Razak A, Mohamad N, Ismail F. Responsible AI for Phytopharmaceutical Innovation: Scientific Validity, Ethical Sourcing, Explainability, Reproducibility, and Clinical Trust. Int J Pharm Phytopharmacol Res. 2025;15(5):34-43. https://doi.org/10.51847/Z3OtH4ranw
APA
Razak, A., Mohamad, N., & Ismail, F. (2025). Responsible AI for Phytopharmaceutical Innovation: Scientific Validity, Ethical Sourcing, Explainability, Reproducibility, and Clinical Trust. International Journal of Pharmaceutical And Phytopharmacological Research, 15(5), 34-43. https://doi.org/10.51847/Z3OtH4ranw
Download citation:   EndNote   RIS
Article Link:
Downloads: 23
Views: 75
Abstract

Artificial intelligence is increasingly used to support phytopharmaceutical innovation through natural product discovery, compound prioritization, mechanism interpretation, safety assessment, and translational decision-making. Yet responsible use of AI in this field requires more than technical model performance, because phytopharmaceutical research involves complex biological materials, variable phytochemical composition, heterogeneous evidence, traditional knowledge contexts, biodiversity concerns, and clinically sensitive interpretations. This article develops an original responsible innovation framework for AI-enabled phytopharmaceutical research. The framework connects scientific validity, botanical and phytochemical integrity, data provenance, ethical sourcing, traditional knowledge sensitivity, biodiversity stewardship, explainability, reproducibility, uncertainty communication, evidence grading, human expert review, clinical trust, translational safeguards, and governance accountability. It argues that AI outputs in phytopharmaceutical innovation should be treated as decision-support evidence rather than proof of efficacy, safety, mechanism, ownership, or clinical readiness. Scientific validity is positioned as the foundation of responsible AI, requiring clear research questions, reliable botanical identity, chemical characterization, data quality, and validation planning. Ethical sourcing is treated as inseparable from scientific trust because provenance, cultural context, benefit-sharing awareness, and ecological stewardship shape the legitimacy of data reuse. Explainability and reproducibility are presented as necessary but insufficient safeguards that must be combined with uncertainty communication and expert review. The framework offers a structured governance logic for cautious, transparent, and evidence-aware AI-enabled phytopharmaceutical innovation.

Related articles:
Most viewed articles:
Naproxen in Pain and Inflammation – A Review
Vol 11 Issue 1, 2021 | Svetoslav Nikolaev Stoev
An Overview on Emulgel
Vol 9 Issue 1, 2019 | Sreevidya V.S
Volume 16
Issue 1
2026

Call for Papers
[email protected]
Issues
Associations
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2026 International Journal of Pharmaceutical and Phytopharmacological Research
Authors retain copyright of their article if they are accepted for publication.